These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs. Cheng PW, Liu SH, Hsu CJ, Lin-Shiau SY. Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519 [Abstract] [Full Text] [Related]
36. Comparison of currently available devices designed for newborn hearing screening using automated auditory brainstem and/or otoacoustic emission measurements. Meier S, Narabayashi O, Probst R, Schmuziger N. Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):927-34. PubMed ID: 15183584 [Abstract] [Full Text] [Related]
37. [The application of otoacoustic emissions in paediatric hearing screening]. Guo Y, Yao D. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug; 18(4):284-7. PubMed ID: 9388977 [Abstract] [Full Text] [Related]
38. [Otoacoustic emissions for newborn hearing screening]. Liao H, Wu Z, Zhou T. Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 34(1):21-4. PubMed ID: 12764789 [Abstract] [Full Text] [Related]
39. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss? Parham K. Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077 [Abstract] [Full Text] [Related]